Pictet Asset Management Sa C4 Therapeutics, Inc. Transaction History

Pictet Asset Management Sa

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$8.03 - $12.77 $1.35 Million - $2.15 Million	168,495 Added 14.82%	1,305,349 $11.4 Million
Q2 2022 Aug 09, 2022	BUY	$5.06 - $26.46 $27,389 - $143,227	5,413 Added 0.48%	1,136,854 $8.57 Million
Q1 2022 May 13, 2022	BUY	$19.99 - $33.23 $1.42 Million - $2.35 Million	70,813 Added 6.68%	1,131,441 $27.4 Million
Q4 2021 Feb 10, 2022	SELL	$29.39 - $46.86 $1.11 Million - $1.77 Million	-37,793 Reduced 3.44%	1,060,628 $34.2 Million
Q3 2021 Nov 12, 2021	BUY	$35.91 - $50.5 $39.4 Million - $55.5 Million	1,098,421 New	1,098,421 $49.1 Million

130

63.5M

670K

54.8K

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $214M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

Stay updated on Pictet Asset Management Sa with notifications on news.